Lassmann A, Rietbrock N
Naunyn Schmiedebergs Arch Pharmacol. 1982 Aug;320(2):189-95. doi: 10.1007/BF00506320.
Binding curves obtained by the stopped-flow method for the association of warfarin and human serum albumin (HSA) at pH 6.0 and 9.0 have been analysed with digital- and analog computers. The first association product (WHSA') at pH 6-9 does not contribute to the observed fluorescence enhancement during warfarin-HSA complex formation. A similar consecutive relaxation process leads to a more stable warfarin-HSA complex, with HSA in the neutral (N)-form (pH 6) and base (B)-form (pH 9). This rearrangement can be measured by stopped-flow (k 2 = 31 s-1 at pH 6; K'2 = 63 s-1 at pH 9). At pH 6 a further concentration dependent relaxation process has been observed indicating that the complex of warfarin with the N-form of HSA gets partially converted into its B-form with a half-time for this N leads to B transition in the range of 0.2-0.4 s. A drug such as warfarin can act as effector molecule for conformational changes of the HSA tertiary and quaternary structure during the formation of a high affinity complex.
通过停流法获得的在pH 6.0和9.0条件下华法林与人血清白蛋白(HSA)结合的曲线已用数字计算机和模拟计算机进行了分析。在pH 6至9时,第一个结合产物(WHSA')在华法林 - HSA复合物形成过程中对观察到的荧光增强没有贡献。类似的连续弛豫过程导致形成更稳定的华法林 - HSA复合物,其中HSA处于中性(N)形式(pH 6)和碱(B)形式(pH 9)。这种重排可以通过停流法测量(在pH 6时k 2 = 31 s-1;在pH 9时K'2 = 63 s-1)。在pH 6时,观察到另一个浓度依赖性弛豫过程,表明华法林与HSA的N形式的复合物部分转化为其B形式,这种N向B转变的半衰期在0.2 - 0.4 s范围内。像华法林这样的药物在形成高亲和力复合物的过程中可以作为效应分子引起HSA三级和四级结构的构象变化。